Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation - PubMed (original) (raw)
P Salven, H Mikkola, R Lassila, J Kaukonen, V Joukov, A Orpana, A Ristimäki, M Heikinheimo, H Joensuu, K Alitalo, A Palotie
Affiliations
- PMID: 9684805
Comparative Study
Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation
U Wartiovaara et al. Thromb Haemost. 1998 Jul.
Abstract
VEGF-C is a recently characterised endothelial growth factor structurally related to vascular endothelial growth factor (VEGF). We studied the expression of VEGF-C and VEGF in the cells of peripheral blood and in the umbilical cord blood CD 34+ cells, representing haematopoietic progenitor cells. Expression of VEGF-C was detected in the CD34+ cells. In peripheral blood VEGF-C mRNA was restricted to platelets and T-cells. In contrast to the expression pattern of VEGF-C, VEGF mRNA was detected in all peripheral blood cell fractions studied, and also in CD34+ cells. VEGF-C mRNA was also detected in fresh bone marrow samples of acute leukaemia patients, but the expression did not show lineage specificity. VEGF-C and VEGF polypeptides were present in platelets and they were released from activated platelets together with the release of beta-thromboglobulin, suggesting that VEGF-C and VEGF reside in the alpha-granules of platelets. VEGF-C and VEGF, released from activated platelets, may have a role in angiogenesis during wound healing, and possibly also in other pathological conditions, such as atherosclerosis, tumour growth, and metastasis formation.
Similar articles
- Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
de Bont ES, Guikema JE, Scherpen F, Meeuwsen T, Kamps WA, Vellenga E, Bos NA. de Bont ES, et al. Cancer Res. 2001 Oct 15;61(20):7654-9. Cancer Res. 2001. PMID: 11606408 - Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
Salven P, Orpana A, Joensuu H. Salven P, et al. Clin Cancer Res. 1999 Mar;5(3):487-91. Clin Cancer Res. 1999. PMID: 10100697 - Platelet: transporter of vascular endothelial growth factor.
Verheul HM, Hoekman K, Luykx-de Bakker S, Eekman CA, Folman CC, Broxterman HJ, Pinedo HM. Verheul HM, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2187-90. Clin Cancer Res. 1997. PMID: 9815613 - [Vascular endothelial growth factor and Crow-Fukase syndrome].
Arimura K, Osame M, Hashiguchi T. Arimura K, et al. Rinsho Shinkeigaku. 2001 Dec;41(12):1144-6. Rinsho Shinkeigaku. 2001. PMID: 12235821 Review. Japanese. - Platelets, inflammation and tissue regeneration.
Nurden AT. Nurden AT. Thromb Haemost. 2011 May;105 Suppl 1:S13-33. doi: 10.1160/THS10-11-0720. Epub 2011 Apr 11. Thromb Haemost. 2011. PMID: 21479340 Review.
Cited by
- Platelet extracellular vesicles preserve lymphatic endothelial cell integrity and enhance lymphatic vessel function.
Vachon L, Jean G, Milasan A, Babran S, Lacroix E, Guadarrama Bello D, Villeneuve L, Rak J, Nanci A, Mihalache-Avram T, Tardif JC, Finnerty V, Ruiz M, Boilard E, Tessier N, Martel C. Vachon L, et al. Commun Biol. 2024 Aug 11;7(1):975. doi: 10.1038/s42003-024-06675-8. Commun Biol. 2024. PMID: 39128945 Free PMC article. - Metastasis and angiogenesis in cervical cancer: key aspects of purinergic signaling in platelets and possible therapeutic targets.
Faria PCL, Resende RS, Cardoso AM. Faria PCL, et al. Purinergic Signal. 2024 Dec;20(6):607-616. doi: 10.1007/s11302-024-10020-3. Epub 2024 May 16. Purinergic Signal. 2024. PMID: 38753131 Free PMC article. Review. - Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
Li DZ, Guo J, Song QK, Hu XJ, Bao XL, Lu J. Li DZ, et al. Transl Cancer Res. 2022 Nov;11(11):4037-4050. doi: 10.21037/tcr-22-1197. Transl Cancer Res. 2022. PMID: 36523315 Free PMC article. - Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels.
Sundblom J, Skare TP, Holm O, Welin S, Braun M, Nilsson P, Enblad P, Sjöström EO, Smits A. Sundblom J, et al. PLoS One. 2022 Nov 28;17(11):e0278166. doi: 10.1371/journal.pone.0278166. eCollection 2022. PLoS One. 2022. PMID: 36441756 Free PMC article. - A systematic review and meta-analysis of preanalytical factors and methodological differences influencing the measurement of circulating vascular endothelial growth factor.
Sjöbom U, Nilsson AK, Gyllensten H, Hellström A, Löfqvist C. Sjöbom U, et al. PLoS One. 2022 Jul 6;17(7):e0270232. doi: 10.1371/journal.pone.0270232. eCollection 2022. PLoS One. 2022. PMID: 35793362 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical